|
|
Volumn 12, Issue 2, 1998, Pages 103-110
|
|
Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
DOXYCYCLINE;
GELATINASE;
METALLOPROTEINASE;
PROTEINASE INHIBITOR;
TETRACYCLINE DERIVATIVE;
ANIMAL;
ARTICLE;
ARTICULAR CARTILAGE;
CANCER INVASION;
CELL CULTURE;
CHEMISTRY;
COMPARATIVE STUDY;
CULTURE MEDIUM;
CYTOLOGY;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
FIBROBLAST;
HUMAN;
LUNG TUMOR;
MELANOMA;
METABOLISM;
METASTASIS;
MOUSE;
MOUSE MUTANT;
PATHOLOGY;
PHYSIOLOGY;
RHEUMATOID ARTHRITIS;
SYNOVIUM;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ARTHRITIS, RHEUMATOID;
CARTILAGE, ARTICULAR;
CULTURE MEDIA, CONDITIONED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXYCYCLINE;
FEMALE;
FIBROBLASTS;
GELATINASES;
HUMANS;
LUNG NEOPLASMS;
MELANOMA;
METALLOENDOPEPTIDASES;
MICE;
MICE, SCID;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
PROTEASE INHIBITORS;
SYNOVIAL MEMBRANE;
TETRACYCLINES;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
|
EID: 0032198175
PISSN: 08959374
EISSN: None
Source Type: Journal
DOI: 10.1177/08959374980120010101 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
